mdlinx mdlinx
Orthopedics Articles on MDLinx Top Read Articles
of 2012
« Return to Article Summary

Hang Them High: A Hands-Free Technique for Limb-Holding During Surgical Preparation



Article Options

Go To PubMed Read Full Abstract, Find Related Articles, and more ... PubMed Link
Go To Abstract Journal of Orthopaedic Trauma - Read Full Abstract, Access Prior Issues ... Publisher Link
Print Article Summary
Related Articles MDlinx Article Summaries on Similar Topics from Clinician-Valued Journals

1 Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial The Lancet Oncology, April 24, 2013

2 Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis American Journal of Clinical Nutrition, May 21, 2013    Evidence Based Medicine    Review Article

3 Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis The Lancet, May 20, 2013

4 The Center for Technology and Aging launches online mHealth toolkit Healthcare IT News, May 3, 2013

5 Obamacare is on the horizon, but will enough people sign up? Reuters Health News, May 7, 2013

6 Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab Clinical Cancer Research, May 8, 2013

7 Virtual health care gaining ground USA Today, May 7, 2013

8 Shoulder mobility, muscular strength, and quality of life in breast cancer survivors with and without Tai Chi Qigong training Evidence-based Complementary and Alternative Medicine , May 6, 2013    Review Article

9 Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial The Lancet Oncology, May 3, 2013

10 Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial The Lancet Oncology, May 3, 2013




Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close